Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies
Journal:
Current Drug Targets
Volume:
7
Page:
1341-1347
Author(s):
Constantine S. Mitsiades, Nicholas Mitsiades, Teru Hideshima, Paul G. Richardson and Kenneth C. Anderson
Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery
Journal:
Current Drug Targets
Volume:
7
Page:
1349-1359
Author(s):
Ingo Ringshausen, Christian Peschel and Thomas Decker
Therapeutic Targeting of Apoptotic Pathways in Cancer
Journal:
Current Drug Targets
Volume:
7
Page:
1361-1369
Author(s):
Johannes Meiler and Martin Schuler
Current status of Immunotherapy in B Cell Malignancies
Journal:
Current Drug Targets
Volume:
7
Page:
1371-1374
Author(s):
D. M. Kofler, C. Mayr and C.-M. Wendtner
Gene Therapy for Dentin Regeneration with Bone Morphogenetic Proteins
Journal:
Current Gene Therapy
Volume:
6
Page:
551-560
Author(s):
Misako Nakashima, Koichiro Iohara and Li Zheng
Potential Gene Therapy Strategies for Cancer Stem Cells
Journal:
Current Gene Therapy
Volume:
6
Page:
579-591
Author(s):
Stewart Sell
Editorial [Hot Topic: New Perspectives in the Treatment of Hematological Malignancies (Guest Editor: Masahiro Kizaki)]
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
313-313
Author(s):
Masahiro Kizaki
DNA Hypermethylation of Myeloid Cells, A Novel Therapeutic Target in MDS and AML
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
315-321
Author(s):
Claudia I. Muller, Bjorn Ruter, H. Phillip Koeffler and Michael Lubbert
Induction of Apoptosis via the Modulation of Reactive Oxygen Species (ROS) Production in the Treatment of Myeloid Leukemia
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
323-329
Author(s):
Masahiro Kizaki, Mingji Xian, Morihiko Sagawa and Yasuo Ikeda
Immunomodulatory Drugs (IMiDs™): A New Treatment Option for Myelodysplastic Syndromes
Journal:
Current Pharmaceutical Biotechnology
Volume:
7
Page:
339-342
Author(s):
Vishakha Kale and Alan F. List